Skip to main content

Table 2 Baseline characteristics of the subjects

From: Analysis of renin-angiotensin aldosterone system gene polymorphisms in malaysian essential hypertensive and type 2 diabetic subjects

Parameters

Group 1

(n-70)

Group 2

(n-60)

Group 3

(n-65)

Group 4

(n-75)

Gender

(male/female)

51/19*

33/27

40/25

39/36

Age

(Years)

57.70 ± 11.02*

57.70 ± 10.24*

57.61 ± 9.76*

45.37 ± 10.69

BMI

(kg/m2)

25.63 ± 4.15*

27.89 ± 3.93*

26.71 ± 3.59*

23.91 ± 4.01

SBP

(mm Hg)

159.44 ± 17.10*

125.93 ± 9.05

160.26 ± 19.01*

125.98 ± 8.81

DBP

(mm Hg)

96.40 ± 6.52*

74.97 ± 7.34

93.60 ± 3.77*

77.83 ± 7.09

FPG

(mmol/L)

5.24 ± 0.54*

11.85 ± 4.81*

11.68 ± 4.71*

4.60 ± 0.91

HDL-C

(mmol/L)

0.86 ± 0.31*

0.73 ± 0.22*

0.78 ± 0.29*

1.11 ± 0.40

LDL-C

(mmol/L)

3.42 ± 1.09

4.04 ± 1.47*

3.76 ± 1.19

3.36 ± 1.16

TG

(mmol/L))

1.97 ± 0.99

2.09 ± 1.01*

1.95 ± 0.87

1.64 ± 0.98

TC

(mmol/L

4.80 ± 1.10

5.14 ± 1.31

5.05 ± 1.26

5.12 ± 1.38

Na

(mEq/L)

144.17 ± 12.78*

133.01 ± 9.60*

137.12 ± 10.11*

114.73 ± 18.38

K

(mEq/L)

4.94 ± 1.15

4.90 ± 0.82

5.24 ± 0.92

5.13 ± 0.89

  1. Data presented as mean ± SD, Group 1- EHT, Group 2 -T2DM, Group 3-EHT+T2DM and Group 4-Control subjects,* P value < 0.05 vs. Group 4